Medical Health Cluster

Ingles

Discontinuation of CDC’s Distribution of Intravenous Artesunate as Commercial Drug is Widely Available in the United States

CDC  has discontinued its distribution of intravenous artesunate for treatment of severe malaria in the U.S. as of September 30, 2022. Commercial intravenous artesunate, Artesunate for InjectionTM, is available in adequate supply from major drug distributors. Severe malaria can rapidly progress to death. Having a plan for rapid diagnosis and […]

Read More

Backslide in Global Childhood Vaccinations

Worldwide childhood vaccinations continued to decline in 2021, fueled by a multitude of factors from COVID-19 to challenging immunization settings, according to a statement by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF). The percentage of children who received 3 doses of the vaccine against diphtheria-tetanus-pertussis (DTP)—a marker […]

Read More

COVID-19 Integrated County View

This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]

Read More

Preventive Medication for COVID-19 Infection

Tixagevimab-cilgavimab is a combination medication to help prevent COVID-19 infection. Tixagevimab-cilgavimab (Evusheld) consists of 2 long-acting monoclonal antibodies that bind to the spike protein of the virus that causes COVID-19 to prevent it from infecting human cells. When Can Tixagevimab-Cilgavimab Be Given? Tixagevimab-cilgavimab is not a treatment for COVID-19 and […]

Read More

Despite Its Fan Base, Newly Authorized “Traditional” Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US

To say that Krystal Lashley went to great lengths to get the Novavax COVID-19 vaccine (NVX-CoV2373) would be a gross understatement. In April, Lashley traveled roughly 3700 miles from her home in Metuchen, New Jersey, to a pharmacy in Paris, France, for her first dose. She then flew to the […]

Read More

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In a recent study published in Indoor Air, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC). Background […]

Read More

Clinical management of COVID-19: Living guideline, 15 September 2022

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ […]

Read More